Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine

This publication has 11 references indexed in Scilit:

• Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: Construction of single and multiple mutants in a full-length cDNA clone
  Virology, 1991
• TC‐83 Venezuelan equine encephalitis vaccine exposure during pregnancy
  Teratology, 1987
• Evaluation in Humans of a New, Inactivated Vaccine for Venezuelan Equine Encephalitis Virus (C-84)
  The Journal of Infectious Diseases, 1979
• Congenital cerebral and ocular malformations induced in rhesus monkeys by Venezuelan Equine Encephalitis virus
  Teratology, 1977
• Persistence in Humans of Antibody to Subtypes of Venezuelan Equine Encephalomyelitis (VEE) Virus after Immunization with Attenuated (TC-83) VEE Virus Vaccine
  The Journal of Infectious Diseases, 1977
• Inactivated Venezuelan Equine Encephalomyelitis Vaccine Prepared from Attenuated (TC-83 Strain) Virus
  Applied Microbiology, 1974
• Recovery of Venezuelan Equine Encephalomyelitis Virus in Panamá
  The American Journal of Tropical Medicine and Hygiene, 1968
• Use of an Attenuated Strain of Venezuelan Equine Encephalo-Myelitis Virus for Immunization in Man
  The American Journal of Tropical Medicine and Hygiene, 1963
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958
• The Causative Agent of Infectious Equine Encephalomyelitis in Venezuela
  Science, 1939